Síndrome neuroléptico maligno: aproximación médico-psiquiátrica / Malignant neuroleptic syndrome: a clinical-psychiatric approach
Giacamán F., Patricio; Andresen Hernández, Max; Gareca T., Néstor; Bitrán C., José; Dougnac L., Alberto.
Rev. méd. Chile
; 125(2): 195-9, feb. 1997. graf
Artículo
en Español
| LILACS | ID: lil-194818
We report the case of a 42 years old male, with a bipolar disorder and receiving lithium therapy, valproic acid and clonazepam. Due to an exacerbation of his underlying disease, he was admitted to a psychiatric clinic and received 50 mg of intramuscular chlorpromazine in 2 ocasions. Afterwards, the patient had an alteration of conciousness, fever reaching 39ºC and generalized muscular rigidity. Laboratory work-up showed a normal brain CT scan, a diffuse slowness in the EEG and a creatinphosphokinase that reached values of 3.040 U/l. He was transferred to an intensive care unit and treated with sodium dantrolene and bromocriptine, obtaining a good clinical response
Biblioteca responsable:
CL1.1
Documentos relacionados